Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Submitted by susan on Wed, 2020-05-27 10:57
The objective of the study was to assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19).
Main Topic:
Mark Content Private(Internal):
External URL:
https://www.bmj.com/content/369/bmj.m1849
Email Alert:
1-11
369
Publication Date:
14/05/2020